Maxim Group is acting as the exclusive placement agent for this offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNRX:
- Quoin Pharmaceuticals Annual Meeting Approves Key Amendments
- Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges
- Quoin Pharmaceuticals reports Q3 EPS ($1.63), consensus (49c)
- Quoin Pharmaceuticals sees cash runway into late 2025
- Quoin Pharmaceuticals continues to evaluate M&A opportunities